The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck

Autor: Henrik Hauswald, Kolja Freier, Alexandra D Jensen, Sati Akbaba, Thomas Held, Marc W. Münter, Vivek Verma, Stefan Rieken, Anna Nikoghosyan, Sebastian Adeberg, Juergen Debus, Klaus Herfarth, Denise Bernhardt, Peter Plinkert, Kristin Lang

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 106:167-173

Purpose The adenoid cystic carcinoma (ACC), Erbitux, and Particle Therapy (ACCEPT) phase 1/2 trial (NCT01192087) evaluated a combined-modality approach (concurrent cetuximab and intensity modulated radiation therapy with carbon ion boost) for newly d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec09522842af98a90424c3873ba04e1d
https://doi.org/10.1016/j.ijrobp.2019.09.036

Persistence of radiation-induced aberrations in patients after radiotherapy with C-ions and IMRT

Autor: Juergen Debus, Sylvia Ritter, Anna Nikoghosyan, Carola Hartel, Martina C. Fuss, Elena Nasonova

Publikováno v: Clinical and translational radiation oncology 13, 57-63 (2018). doi:10.1016/j.ctro.2018.10.002
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 13, Iss, Pp 57-63 (2018)

Clinical and translational radiation oncology 13, 57 - 63 (2018). doi:10.1016/j.ctro.2018.10.002
Background and purpose:Chromosomal aberrations in peripheral blood lymphocytes are a biomarker for radiation exposure and are associated with an inc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b912132f22ce4bccbc0796b1694fa9a
https://doi.org/10.1016/j.ctro.2018.10.002

Co-Optation of Feminism: Gender, Militarism and the UNSC Resolution 1325

Autor: Anna Nikoghosyan

Publikováno v: Feminist Critique: East European Journal of Feminist and Queer Studies. :7-18

United Nations Security Council Resolution 1325 is often referred to as a landmark resolution. Despite its revolutionary potential, I argue that the Resolution was developed through gendered discourses that allowed its use for militarist purposes. In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a4840893c59f68b7330ab9e724f45ea0
https://doi.org/10.52323/fc1-1

High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years’ experience with raster-scanned carbon ion therapy

Autor: Melanie Poulakis, Thomas Haberer, Daniela Schulz-Ertner, Thomas Welzel, Oliver Jäkel, Anna Nikoghosyan, Angelika Höss, Matthias Uhl, Peter E. Huber, Jürgen Krauss, Kolja Freier, Marc W. Münter, Alexandra D Jensen, Jürgen Debus, Philippe A. Federspil

Publikováno v: Radiotherapy and Oncology. 118:272-280

Purpose Locoregional control (LC) in malignant salivary gland tumors is dose-dependent, initial results with particle therapy were promising. We report our experience with raster-scanned, intensity-controlled carbon ion therapy (C12) and IMRT in 309

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12ee7ab28e0aa2b9eafedbfad531dbf
https://doi.org/10.1016/j.radonc.2015.05.010

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial

Autor: Anna Nikoghosyan, Marc W. Münter, Oliver Jäkel, Thomas Haberer, Jürgen Debus, Karen Lossner, Alexandra D Jensen

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 93:37-46

Purpose To investigate the effect of intensity modulated radiation therapy (IMRT) and dose-escalated carbon ion (C12) therapy in adenoid cystic carcinoma (ACC) and other malignant salivary gland tumors (MSGTs) of the head and neck. Patients and Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3e91bc0bc86b5994d9a4244239976b
https://doi.org/10.1016/j.ijrobp.2015.05.013